内心肌氧化合成酶和冠状动脉内皮功能在人类心脏全移植中的表达
S M Wildhirt1, M Weis, C Schulze
1Department of Cardiac Surgery, Ludwig-Maximilians University, Munich, Germany.
Circulation
|September 25, 2001
概括
诱导性氧化合成酶 (iNOS) 与心脏移植中的微血管内皮功能障碍有关. 早期的iNOS表达和氧化的产生表明它在移植动脉样硬化发育中的作用.
科学领域:
- 心血管研究研究心血管研究
- 移植免疫学 移植免疫学
- 内皮细胞生物学 内皮细胞生物学
背景情况:
- 诱导性氧化合成酶 (iNOS) 在移植动脉样硬化中具有活性.
- 在没有先前病变的情况下,早期iNOS参与微血管内皮功能障碍是未知的.
- 在所有移植中早期iNOS的预测值是有趣的.
研究的目的:
- 在人类心脏全移植中研究iNOS mRNA表达和氧化生产.
- 评估iNOS和微血管冠状动脉内皮功能障碍之间的关联.
- 为了确定早期iNOS参与的预后价值.
主要方法:
- 研究了42名心脏移植患者在移植后的1,6和12个月.
- 使用多普勒流线评估微血管冠状动脉流速储量 (CFVR).
- 量化了iNOS mRNA,蛋白质,甲酸氨酸和跨心脏酸盐/酸盐 (NOx) 水平.
主要成果:
- 在1个月后的26.1%和12个月后的31%观察到CFVR受损.
- 患有CFVR受损的患者表现出 iNOS基因表达增加和更高的 iNOS mRNA水平.
- 在内心肌血管中存在iNOS蛋白和尼铁;在CFVR受损的人中,NOx释放量更高.
结论:
- 心脏全移植中的微血管内皮功能障碍与增加的iNOS mRNA和NOx生产有关.
- 尼铁的表达表明过氧酸盐参与了疾病过程.
- 在移植后,iNOS/氧化途径在调节微血管功能方面发挥着重要作用.
更多相关视频
08:03Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
1.6K
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
1.7K
相关概念视频
Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
